Category Archives: Supply Chain


With Growth Rates Stagnating In Developed Markets, What Is A Med-Tech Exec To Do?

Push for growth in emerging markets like Brazil, Russia, India and China (BRIC).
For some Med-Tech Companies, growth rates in emerging markets are double, triple and in some cases 10-fold those in the US and other developed markets. This trend was clearly evident as I listened to and reviewed transcripts from Q4 2012 earnings calls from Johnson & Johnson, Boston Scientific, and Medtronic.

While emerging markets continue to present significant growth opportunities, how can med-tech companies address the variety of needs and delivery models in these markets, while addressing increasing pricing pressures in developed economies?

Continue reading


Are “Black Swans” Colliding with your Supply Chain?

How can med-tech organizations minimize supply chain disruptions and increase predictability resulting from events characterized by rarity, high impact and low predictability?

By Daniel R. Matlis

Black Swan events once seemed extremely rare and had little or no impact on med-tech supply chains. In recent years, however, natural disasters including super-storm Sandy in northeastern US, the earthquake and tsunami in north-east Japan, flooding in Thailand, and the ash cloud from the Grimsvotn volcano in Iceland have all had significant impact on global supply chains.

Continue reading